Published • loading... • Updated
HIV prevention injection approved in EU amid calls for increased accessibility
Summary by GCN
2 Articles
2 Articles
HIV prevention injection approved in EU amid calls for increased accessibility
In August 2025, the European Commission formally approved the twice-yearly injection for HIV prevention developed by Gilead Sciences, making it available for countries in the EU. Since the jab was authorised in the US earlier in June, experts and activists have called on Gilead to make the drug more accessible.
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium